Company Active ROYAL-CHARTER

Company profile

University College London

UK company RC000631, incorporated on 1 January 1981.

Welcome to UCL | University College London

Two centuries ago, our founders had a vision: to open higher education to all. Today, we are a world top-ten university in the heart of London, with a thriving community from over 150 countries.

Company number
RC000631
Incorporated
1 Jan 1981
Companies House status
Active

Company identity

Founded / incorporated
1 January 1981

Company number RC000631

Verify at Companies House
Legal name
UNIVERSITY COLLEGE LONDON
Company type
ROYAL-CHARTER
Region
Unknown
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

University College London
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

1 event
01 Jan
1981

Incorporated

Inception

Company registered at Companies House

Public funding

397 awards
First funded
2003
Funded years
2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026
Age at first award
22 years

Projects

2026 Legacy Department of Trade & Industry

Cryogenic Hydrogen Aerospace Motor Pump (CHAMP)

1 Sep 2026 to 31 Aug 2030

Awarded
£460,313
Total cost £460,313

**The objective of the CHAMP (Cryogenic Hydrogen Aerospace Motor Pump) project** is to develop **state-of-the-art liquid hydrogen fuel pumping technology** specifically for a **new generation of commercial hydrogen powered aircraft**. CHAMP is a collaboration between industry and academic experts from Eaton, Airbus, Advanced Design Technology (ADT), Unive...

2026 Collaborative R&D

Dragonfly: democratising bespoke, secure technology stack design for SMEs

1 Aug 2026 to 31 Jan 2028

Awarded
£268,955
Total cost £268,955

**The problem.** Small and medium-sized businesses across the UK now run hundreds of software tools. Nearly half are redundant, many share data through insecure methods like CSV exports and shared passwords, and over 65% of software in use was adopted without IT oversight (shadow IT). This fragmented, poorly secured software infrastructure costs the UK ec...

2026 Collaborative R&D

Feasibility Study of a Sustainable UK Supply Chain Process for Converting Waste Titanium Powder into High‑Value Wire Using Conform™ Technology (Ti2Wire-FS)

1 Jul 2026 to 31 Dec 2026

Awarded
£45,075
Total cost £45,075

Titanium powder production for additive manufacturing (AM) in commercial aerospace is highly inefficient. The most widely used production route, Electrode Induction Gas Atomisation (EIGA), generates a broad powder size range, but only a small portion is suitable for AM. As a result, **around 75% of the powder produced falls outside specification and becom...

2025 Collaborative R&D

MORSE.02 - MOFs for Reduction of Ship Emissions

1 Sep 2025 to 31 Mar 2026

Awarded
£232,955
Total cost £232,955

MORSE.02 -- MOFs for Reduction of Ship Emissions is an innovative, collaborative project led by C‑MAT Technologies in partnership with University College London (UCL) and the Natural Environment Research Council (NERC). The project aims to develop and demonstrate an advanced onboard carbon capture system that significantly reduces greenhouse gas emissions...

2025 Legacy Department of Trade & Industry

Wing IntegRATE_1

1 Jul 2025 to 30 Jun 2028

Awarded
£899,876
Total cost £899,876

**IntegRATE\_1** will develop the Wing Assembly Industrial technologies which are required to assemble the wings for Airbus's Next Generation Single-Aisle (NGSA) commercial aircraft, which will incorporate new ultra-efficient engines. The Next Generation Single-Aisle (NGSA) commercial aircraft will be capable of using 100% Sustainable Aviation Fuel (SAF)....

2025 Collaborative R&D

Demonstrator of urban building energy assessment technology combined with AI methodology for an innovative transition to net-zero buildings

1 Jul 2025 to 31 Mar 2027

Awarded
£96,765
Total cost £96,765

UK Partners' MapMortar and UCL, as well as South Korea partners', Phase 2 demonstrator builds on an exceptionally successful Phase 1 feasibility study, transforming groundbreaking business-led R&D and proof-of-concept innovations into real-world deployment and testing. Phase 1 proved the technical feasibility of integrating AI with physics-based Urban Bui...

2025 Collaborative R&D

Software Hyperspectral Imaging for Precision Surgery (En-Surge)

1 Jul 2025 to 31 Dec 2026

Awarded
£17,582
Total cost £17,582

In colorectal surgery, the surgeon removes the tumour-affected bowel section and reconnects the two healthy bowel ends to form an 'anastomosis'. An insufficient oxygenated blood flow to the reconnected bowel can lead to anastomotic leaks (AL). Patients with AL have the risks: * 19.7% being readmitted for further treatment chance * 19.3% getting an infecti...

2025 Collaborative R&D

Navigo: Transforming English Language Education through Personalised, AI-Driven Learning.

1 May 2025 to 31 Oct 2026

Awarded
£233,725
Total cost £233,725

Navigo is an ambitious project designed to revolutionise how young learners across the globe acquire English as a Foreign Language (EFL). Leveraging the power of cutting-edge Artificial Intelligence (AI), Navigo combines innovative technology with world-class educational research to create an engaging, adaptive, and personalised learning experience. Build...

2025 Collaborative R&D

SiQEC - Silicon Quantum Error Correction

1 Apr 2025 to 31 Mar 2026

Awarded
£167,098
Total cost £167,098

The SiQEC (Silicon Quantum Error Correction) project aims to deliver the first demonstration of a spin-based quantum computing system capable of implementing repeated rounds of quantum error correction (QEC) - a critical milestone toward fault-tolerant quantum computing. This collaboration between Quantum Motion and University College London will introduc...

2025 Collaborative R&D

CLEARED (CLinical Evaluation & Assessment for REgulation of Diagnostic tests) Implementation Phase

1 Feb 2025 to 31 Mar 2026

Awarded
£154,431
Total cost £154,431

Our network will focus on assisting the efficient and safe availability of medical diagnostic tests in the UK, by building a collaborative network of regulators, industry, people living with disease and users of tests and researchers. Efficient regulation of diagnostic tests not only assists patient and consumer safety, but also improves the nation's heal...

2025 EU-Funded Lead participant

The META Trial: PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA: A RANDOMISED PLACEBO -CONTROLLED DOUBLE-BLIND PHASE III TRIAL OF METFORMIN IN HIVINFECTED PERSONS WITH PRE-DIABETES

1 Jan 2025 to 31 Dec 2026

Awarded
£475,200
Total cost £475,200

Diabetes is a common co-morbidity among people living with HIV. Since Oct 2021, we have been conducting a phase III randomised placebo-controlled trial of metformin among people living with HIV and pre-diabetes in Dar es Salaam, Tanzania (EDCTP RIA2018CO-2513). The aim isto test whether metformin can prevent progression to diabetes among people living wit...

2024 EU-Funded Lead participant

CATCR: Central Africa Training Platform for Clinical Research on infectious diseases

1 Nov 2024 to 30 Apr 2029

Awarded
£154,907
Total cost £154,907

The world is facing the silent “pandemic” of antimicrobial resistance (AMR). Central Africa has the highest mortality rate (23.5 deaths/ 100,000) attributable to AMR in the world. Research is desperately needed to better understand the burden of AMR in this region, and it is vital that this work is done by local researchers who will be the future leaders ...

Product types

BEIS-Funded Programmes BIS-Funded Programmes Centres Collaborative R&D CR&D Bilateral EU-Funded European Enterprise Network Fast Track Feasibility Studies Knowledge Transfer Network Knowledge Transfer Partnership Legacy Department of Trade & Industry Missions Responsive Strategy and Planning SME Support Study Unknown